$1.14
0.0% Today
as of Oct 22, 16:45 ET
Last 30 days
Recent Press Releases & News
Acurx Announces Publication in ASM Confirming Data on its DNA pol IIIC Inhibitor Pipeline of Antibiotics Demonstrating a Potential Microbiome-Sparing Class Effect
Acurx Pharmaceuticals Takes Its Antibiotics Story Global Through a 12-Month Series with New to The Street
Acurx Pharmaceuticals Announces First Patient Enrolled in PATHFINDER Clinical Trial of Ibezapolstat in Multiply-Recurrent C. difficile Infection
ACXP earnings at a glance
Over its last 2 reports the stock rose the next day 2 times and fell 0, moving ±7.0% on average; after the most recent report on May 11, 2026 it moved +4.3%. ACXP beat the consensus EPS estimate in 2 of its last 3 reported quarters. The share price of $1.14 sits near its 52-week low.
Overview
52-week range
$1.07
$7.54
1% of range
Avg surprise (last 3)
+8.0%
Avg reaction (last 2)
+7.0%
100% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.53 | — | — | — | — | financials |
| Mon May 11, 2026 | Mar/2026 | $-0.62 | $-0.59 | -5.1% | -463.6% | +4.3% | earnings |
| Wed Nov 12, 2025 | Sep/2025 | $-1.23 | $-1.61 | +23.6% | — | — | earnings |
| Mon Aug 11, 2025 | Jun/2025 | $-1.89 | $2.00 | +5.5% | — | — | earnings |
| Mon May 12, 2025 | Mar/2025 | $-0.11 | — | — | — | +9.7% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-3.45 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-5.21 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.28 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.24 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.28 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.25 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-2M | $-2M | — | $-2M | $-2M | $-2M | — | $-3M |
| Net income | $-2M | $-2M | — | $-2M | $-2M | $-2M | — | $-3M |
| EPS (diluted) | $-0.53 | $-0.62 | — | $-1.23 | $-1.89 | $-2.15 | — | $-3.45 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $11M | $9M | $8M | $6M | $6M | $5M | — | $6M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | — | — | — | — | $6M | $5M | $4M | $6M |
| Total assets | $11M | $10M | $8M | $6M | — | — | $4M | — |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $3M | $3M | $2M | $2M | $3M | $2M | $3M | $3M |
| Total equity | $8M | $7M | $5M | $4M | $4M | $2M | $615,121 | $3M |
Implied volatility — last 90 days
No IV snapshots yet for ACXP.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
ACXP earnings FAQ
How does ACXP stock usually react to earnings?
Across the last 2 reports the average next-day move was ±7.0%, up 2 times and down 0 times.